There were no statistically significant differences in the mean age, gender distribution, disease stage (stages I, II, III, and IV), resection (R) status, or tumor differentiation among the patients with a high co-expression or a neg/low co-expression of MRP2/CXCR4/PD-L1 (Table 3). This evidence concerns the gene CXCR4 and neoplasm.